Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
暂无分享，去创建一个
K. McHugh | H. Brisse | G. Vassal | B. Morland | F. Giammarile | J. Chisholm | C. Baunin | C. Bergeron | V. Mosseri | D. Valteau‐Couanet | R. Hobson | H. Rubié | L. Biassoni | C. Munzer | C. Coze | A. Defachelles | C. Weston | A. Auvrignon | L. Djafari | F. Dickinson